These findings have raised the question whether TNFRSF13B/TACI mutations contribute to the pathogenesis of human pathologic conditions similar to those observed in TACI-deficient mice, or diseases with clinical manifestations similar to those observed in CVID, such as sarcoidosis. The gene discussed is TNFRSF13B; the disease is sarcoidosis.